"id","uuid:ID","description","instanceType","name","label","text"
"Objective_1","2ff8ef7f-39b5-4297-9622-6ba9be4f809c","Main objective","Objective","OBJ1","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"Objective_2","fdcaac10-e36e-406c-8745-32dd985bff28","Safety","Objective","OBJ2","","To document the safety profile of the xanomeline TTS."
"Objective_3","a8d4fb4f-778b-4292-bfe5-ba08703b3e89","Behaviour","Objective","OBJ3","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
